McDermott Will & Schulte, a global law firm

Margaret J. Sampson, PhD, focuses her practice on global, strategic intellectual property transactions, and patent counseling surrounding the areas of life sciences, pharmaceuticals, research tools, and medical devices. Life sciences and technology clients turn to her for evaluating, structuring, negotiating, and documenting major transactions.

Margaret’s extensive experience includes advising clients in evaluating patent portfolio positions; analyzing freedom-to-operate issues; identifying and evaluating targets for potential investment, mergers, or acquisitions; Hatch-Waxman patent litigation; patent term extensions and adjustments; and patent office proceedings.

She is highly skilled in a variety of transactions such as inbound and outbound licensing and option agreements, development and collaboration agreements, clinical research agreement, clinical and commercial supply agreements, manufacturing agreements, sponsored research agreements, technology transfers, and royalty monetization transactions.

Margaret also has a significant research background, focused on molecular genetics, recombinant DNA and stem cell research, including making mouse knock-out models to better understand the function of genes in an organism.

During law school, Margaret was editor-in-chief of the Texas Intellectual Property Law Journal.